The following article is written by Brian Williamson, PharmD, is president & CEO of JCB Laboratories. It is reprinted, with permission, from the JCB Labs Blog. Over the past five years, the United States has seen record high drug…
The Latest
Anterior cervical discectomy and fusion is a surgical procedure performed to remove a herniated or degenerative disc in the cervical spine. While this procedure has been present in hospitals for some time, surgery centers are just starting to adopt it…
Last year, average case volume, revenue per case and staff and physician salaries increased, according to VMG Health's Multi-Specialty ASC Intellimarker 2011 when compared to 2010. However, the number of procedures performed in the ASC setting remained the same. The…
Nancy E. Cline, MD, has been named a partner at Shelby Eye Centers in Shelby, N.C. and Gaffney, S.C., according to a Shelby Star report.
NinePoint Medical received FDA 510(k) clearance for its Nvision VLE Imaging System, a high-resolution optical imaging technology for use as an imaging tool in the evaluation of human tissue microstructure, according to a news release.
Julie Shimer, president and CEO of Welch Allyn, a manufacturer of frontline medical products and solutions, will retire at the end of 2012 after leading the company for the past five years, according to a news release.
Researchers found spinal manipulation therapy was more effective in reducing neck pain than medication, according to findings published in the Annals of Internal Medicine.
Arcion Therapeutics, a Baltimore-based clinical stage biotechnology company, received notice of allowance for a U.S. patent for its high-strength gel formulation of topical lidocaine, called ARC-2022, for pain associated with post-herpetic neuralgia and shingles, according to a company news release.
GI Dynamics, an obesity and diabetes device maker, continued its global expansion with the launch of its EndoBarrier gastrointestinal sleeve in the Netherlands, according to a MassDevice report.
German researchers found a mutation in the TFAP2E gene might play a part in chemo-resistant colorectal cancer, according to findings published in the New England Journal of Medicine.